The problem of resistance to antibiotics requires the development of new
classes of broad-spectrum antimicrobial drugs. The concept of pro-drugs allows
researchers to look for new approaches to obtain effective drugs with improved
pharmacokinetic and pharmacodynamic properties. Thiosulfinates, formed
enzymatically from amino acid sulfoxides upon crushing cells of genus
Allium plants, are known as antimicrobial compounds. The
instability and high reactivity of thiosulfinates complicate their use as
individual antimicrobial compounds. We propose a pharmacologically
complementary pair: an amino acid sulfoxide pro-drug and vitamin B6 –
dependent methionine γ-lyase, which metabolizes it in the patient’s
body. The enzyme catalyzes the γ- and β-elimination reactions of
sulfoxides, analogues of L-methionine and L-cysteine, which leads to the
formation of thiosulfinates. In the present work, we cloned the enzyme gene
from Clostridium sporogenes. Ionic and tautomeric forms of the
internal aldimine were determined by lognormal deconvolution of the holoenzyme
spectrum and the catalytic parameters of the recombinant enzyme in the γ-
and β-elimination reactions of amino acids, and some sulfoxides of amino
acids were obtained. For the first time, the possibility of usage of the enzyme
for effective conversion of sulfoxides was established and the antimicrobial
activity of thiosulfinates against Gram-negative and Gram-positive bacteria
in situ was shown.